+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are studying the use of intravenous tenecteplase for patients with acute ischemic stroke AIS. This trial aims to determine the best dose of tenecteplasestandard-dose 0.25 mgkg versus low-dose 0.18 mgkgand whether to use tenecteplase or no thrombolysis in specific patient groups, including those recently using direct oral anticoagulants DOACs and those planned for emergency endovascular thrombectomy EVT. The study addresses uncertainties in dosing and safety for various patient subgroups, such as the elderly, patients with comorbidities, and those with different brain imaging findings. Participants will be randomly assigned to receive either standard-dose or low-dose tenecteplase as a single intravenous bolus, or no tenecteplase if they are on recent DOACs or planned for EVT. The doses are administered quickly after randomization. The trial compares these approaches to find the most effective and safe use of tenecteplase for AIS treatment. The study follows participants for 90 days after treatment to assess outcomes. During the study, researchers will assess participants functional independence using the modified Rankin Scale at 90 days, along with mortality, quality of life, and imaging outcomes. Safety events like intracranial hemorrhage and serious adverse events will be monitored closely, especially within the first days after treatment. Participants will have assessments including telephone follow-ups, hospital discharge status, and brain imaging evaluations. The total participation lasts up to 90 days or until death if earlier.

Age: 18Years +All GendersPhase 3
24 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the Small Steps for Big Changes SSBC program, a diet and exercise counseling initiative aimed at reducing the risk of developing Type 2 Diabetes T2D among adults with prediabetes. This study partners with YMCAs across eight Canadian provinces to scale up and assess both the implementation and effectiveness of SSBC in diverse urban communities. The research focuses on how well the program is delivered and its impact on patient health outcomes over time. Participants engage in the SSBC program, which includes six sessions over four consecutive weeks. Each session offers 20 to 30 minutes of counseling to build self-regulation skills for healthy eating and exercise, followed by 20 to 30 minutes of supervised aerobic exercise. The program is delivered by YMCA community facility trainers, and participants also complete three additional exercise sessions independently. There is no randomization all enrolled individuals receive the same intervention. During the study, participants are observed for up to two years after completing the program. Researchers measure changes in diabetes status, blood sugar levels, weight, fitness, diet, and exercise habits. They also track program adoption, attendance, delivery costs, and participant satisfaction. Assessments include health questionnaires, physical measures, and healthcare resource use, helping to understand both the clinical and cost-effectiveness of SSBC over time.

Age: 18Years +All Genders
12 locations